Uric acid and risk of heart failure: A systematic review and meta-analysis

European Journal of Heart Failure

Volumn 16, Issue 1, 2014, Pages 15-24

  Huang, He ^a   Huang, Baotao ^a   Li, Yulin ^b   Huang, Yan ^a   Li, Jing ^a   Yao, Hongmei ^a   Jing, Xianchao ^a   Chen, Jianrong ^a   Wang, Ji ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Heart failure; Meta analysis; Risk factor; Systematic review; Uric acid

Indexed keywords

URIC ACID;

ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR MORTALITY; CONFIDENCE INTERVAL; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HUMAN; HYPERURICEMIA; INCIDENCE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PURINE METABOLISM; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL;

HEART FAILURE; META-ANALYSIS; RISK FACTOR; SYSTEMATIC REVIEW; URIC ACID;

HEART FAILURE; HUMANS; HYPERURICEMIA; INCIDENCE; PROGNOSIS; RISK FACTORS; URIC ACID; WORLD HEALTH;

EID: 84896905770     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft132     Document Type: Article

References (59)

1. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR. Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004;90:155-159.
2. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115:2526-2532.
3. Madero M, Sarnak MJ, Wang X, Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V. Uric acid and long-term outcomes in CKD. Am J Kidney Dis 2009;53:796-803.
4. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001;37:1069-1074.
5. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010;62:170-180.
6. Grayson PC, Kim SY, La Valley M, Choi HK Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:102-110.
7. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. EurJ Heart Fail 2012;14:803-869.
8. Krishnan E. Hyperuricemia and incident heartfailure. Circ Heart Fail 2009;2:556-562.
9. Ekundayo OJ, Dell'Italia LJ, Sanders PW, Arnett D, Aban I, Love TE, Filippatos G, Anker SD, Lloyd-Jones DM, Bakris G, Mujib M, Ahmed A. Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. IntJ Cardiol 2010;142:279-287.
10. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-1997.
11. Pascual-Figal DA, Hurtado-Martinez JA, Redondo B, Antolinos MJ, Ruiperez JA, Valdes M. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. EurJ Heart Fail 2007;9:518-524.
12. Hamaguchi S, Furumoto T, Tsuchihash-Makaya M, Goto K, Goto D, Yokota T, Kinugawa S, Yokoshiki H, Takeshita A, Tsutsui H; JARE-CARD Investigators. Hyperuricemia predicts adverse outcomes in patients with heart failure. IntJ Cardiol 2011;151:143-147.
13. Tamariz L, Harzand A, Palacio A, Verma S Jones J, Hare J. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail 2011;17:25-30.
14. Greenland S. Can meta-analysis be salvaged? Am J Epidemiol 1994;140:783-787.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
17. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
19. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. JRStatSoc SerA 1988;151:419-463.
20. Bae JH, Hyun DW, Kwon TG, Yoon HJ, Lerman A, Rihal CS. Serum uric acid is associated with cardiovascular events in patients with coronary artery disease. Korean CircJ 2007;37:161-166.
21. Holme I, Aastveit AH, Hammar N Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417, 734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009;266:558-570.
22. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. AmJ Cardiol 2012;109:486-491.
23. Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G, Marchionni N, Tavazzi L; IN-CHF Investigators. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 2012;22:442-448.
24. Niizeki T, Takeishi Y, Arimoto T, Okuyama H, Nozaki N, Hirono O, Tsunoda Y, Watanabe T, Nitobe J, Miyashita T, Takahashi H, Koyama Y, Kubota I. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure. J Cardiol 2006;47:219-228.
25. Jankowska EA, Ponikowska B, Majda J, Zymlinski R, Trzaska M, Reczuch K, Borodulin-Nadzieja L, Banasiak W, Ponikowski P. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. IntJ Cardiol 2007;115:151-155.
26. Koyama Y, Takeishi Y, Arimoto T, Niizeki T, Shishido T, Takahashi H, Nozaki N, Hirono O, Tsunoda Y, Nitobe J, Watanabe T, Kubota I. High serum level of pento-sidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure. J Card Fail 2007;13:199-206.
27. Naruszewicz M, Jankowska EA, Zymlinski R, Bukowska H, Millo B, Banasiak W, Ponikowski P. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance-pilot study. Atherosclerosis 2007;194:408-414.
28. Wang HL Level of uric acid and its effect on prognosis in chronic heart failure. Chin J Cardiovasc Rehabil Med 2007;16:554-556.
29. Jindrich S, Ondrej L, Viktor M, Zbynek P, Tomas P, Ladislav D Jiri V, Lenka S, Mirslav S. The profile and prognosis of patients hospitalised with heart failure. The value of discharge blood pressure amd cholesterol. Int Heart J 2008;49:691-705.
30. Dou LH. Uric acid in chronic heart failure and its clinical value. Shandong Med 2008;48:75-76.
31. Austin J, Williams WR, Hutchison S. Multidisciplinary management of elderly patients with chronic heart failure: five year outcome measures in death and survivor groups. EurJ Cardiovasc Nurs 2009;8:34-39.
32. Lainscak M, Hodoscek LM, Dungen HD, Rauchhaus M, Doehner W, Anker SD, Von Haehling S. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr 2009;121:309-313.
33. Guo XY Observation on uric acid level in chronic heart failure. Chin J Primary Med Pharm 2009;16:286-287.
34. Yang JH, Ni RG. Clinical value of uric acid in chronic heart faiure. Med Innovation China 2009;6:78-79.
35. Kim H, Shin HW, Son J, Yoon HJ, Park HS, Cho YK, Han CD, Nam CW, Hur SH, Kim YN, Kim KB. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level. Congest Heart Fail 2010;16:153-158.
36. Masuda K, Yamashita T, Enomoto N, Asada K, Shoji M, Otsuka T, Sagara K, Sawada H, Aizawa T Association between hyperuricemia and prognosis in japanese patients with heart failure. Eur HeartJ 2010;31(Suppl):131.
37. Novack V, Pencina M, Zahger D, Fuchs L, Nevzorov R, Jotkowitz A, Porath A. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One 2010;5:e12184.
38. Wu AH, Ghali JK, Neuberg GW, O'Connor CM, Carson PE, Levy WC. Uric acid level and allopurinoluseas risk markers of mortality and morbidity in systolic heart failure. Am HeartJ 2010;160:928-933.
39. Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, Sanders PW, Pitt B, Anker SD, Ahmed A. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur HeartJ 2011;32:712-720.
40. Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, Van Veldhuisen DJ, Cohen-Solal A, Coats AJ, Poole-Wilson PP, Flather MD; SENIORS Investigators. Predictors of clinical outcomes in elderly patients with heart failure. EurJHeart Fail 2011;13:528-536.
41. Herrmann R, Sandek A, Von Haehling S, Doehner W, Schmidt HB, Anker SD, Rauchhaus M. Risk stratification in patients with chronic heart failure based on meta-bolic-immunological, functional and haemodynamic parameters. IntJ Cardiol 2012;156:62-68.
42. Gotsman I, Keren A, Lotan C, Zwas DR. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival. J Card Fail 2012;18:694-701.
43. Zhao QY, Yu SB, Huang H, Cui HY, Qin M, Huang T, Huang CX. Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. Chin Med J (Engl) 2012;125:1708-1712.
44. Malek F, Ost'ádal P, Parenica J, Jarkovsky J, Vítovec J, Widimsky P, Linhart A, Fedorco M, Coufal Z, Miklík R, Kruger A, Vondrakova D, Spinar J. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure-results of the Acute HEart FAilure Database registry. J Crit Care 2012;27:737 e711-724.
45. Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G; GISSI-HF Investigators. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram. Circ Heart Fail 2013;6:31-39.
46. Larina VN, Bart BY, Vartanyan EA. Factors effecting the decompensation of chronic heart failure in the elderly. Rational Pharmacother Card 2013;9:15-24.
47. Tekin G, Tekin YK, Erbay AR, Turhan H, Yetkin E. Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. Angiology 2013;64:300-303.
48. Misra D, Zhu Y, Zhang Y, Choi HK The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. Semin Arthritis Rheum 2011;41:471-476.
49. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H; VHM&PP Study Group. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83, 683 Austrian men. Clin Chem 2008;54:273-284.
50. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H; VHM&PP Study Group. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28, 613 elderly women: a prospective 21-year follow-up study. IntJ Cardiol 2008;125:232-239.
51. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009;61:225-232.
52. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003;107:1951-1953.
53. Bergamini C, Cicoira M, Rossi A, Vassanelli C. Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. EurJ Heart Fail 2009;11:444-452.
54. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002;105:2619-2624.
55. Gavin AD, Struthers AD. Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart 2005;91:749-753.
56. Doehner W, Von Haehling S, Anker SD. Uric acid in CHF: markeror player in a metabolic disease? IntJ Cardiol 2007;115:156-158.
57. Struthers AD, Donnan PT, Lindsay P, McNaughton D, Broomhall J, MacDonald TM. Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study. Heart 2002;87:229-234.
58. Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, Kinugawa T, Igawa O, Hisatome I, Shigemasa C, Anker SD, Doehner W. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010;3:73-81.
59. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.